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Abstract
Retinal ischemia could provoke blindness. At present, there is no effective treatment against retinal ischemic damage.
Strong evidence supports that glutamate is implicated in retinal ischemic damage. We investigated whether a brief period
of global or ocular hypothermia applied 24 h before ischemia (i.e. hypothermic preconditioning, HPC) protects the retina
from ischemia/reperfusion damage, and the involvement of glutamate in the retinal protection induced by HPC. For this
purpose, ischemia was induced by increasing intraocular pressure to 120 mm Hg for 40 min. One day before ischemia,
animals were submitted to global or ocular hypothermia (33uC and 32uC for 20 min, respectively) and fourteen days after
ischemia, animals were subjected to electroretinography and histological analysis. Global or ocular HPC afforded significant
functional (electroretinographic) protection in eyes exposed to ischemia/reperfusion injury. A marked alteration of the
retinal structure and a decrease in retinal ganglion cell number were observed in ischemic retinas, whereas global or ocular
HPC significantly preserved retinal structure and ganglion cell count. Three days after ischemia, a significant decrease in
retinal glutamate uptake and glutamine synthetase activity was observed, whereas ocular HPC prevented the effect of
ischemia on these parameters. The intravitreal injection of supraphysiological levels of glutamate induced alterations in
retinal function and histology which were significantly prevented by ocular HPC. These results support that global or ocular
HPC significantly protected retinal function and histology from ischemia/reperfusion injury, probably through a glutamate-
dependent mechanism.
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Introduction
Retinal ischemia plays a key role in some of the most
common blinding diseases, such as diabetic retinopathy,
glaucoma, retinal vascular occlusions, and retinopathy of
prematurity, among others. In ischemic retinas, the metabolic
requirements exceed the capacity of the circulation, and the
tissue suffers from lack of nutrients, hypoxia, and build-up of
waste products, which may ultimately lead to cell death [1]. In
addition, reperfusion with oxygenated blood after ischemia has
also the potential to aggravate ischemic damage, an effect
known as reperfusion injury.
Glutamate, the main excitatory neurotransmitter in the retina,
is toxic when present in excessive amounts. Therefore, an
appropriate clearance of synaptic glutamate is required for the
normal function of retinal excitatory synapses and neurotoxicity
prevention. In fact, several lines of evidence strongly support the
involvement of glutamate in retinal ischemic damage. In that
context, it was shown that electrophysiological and neuronal
damage following ischemia resembles that caused by exposure to
glutamate [2-4], and that retinal ischemia induces a significant
increase in glutamate release [5,6]. Moreover, glutamate antago-
nists or inhibitors of glutamate release prevent retinal ischemic
damage [7,8]. At present, there is no effective treatment to protect
the retina from ischemia/reperfusion (I/R) damage. Therefore,
the development of resources to protect the retina against ischemia
is a goal of vast clinical importance. An option to increase the
retina’s resistance to ischemic injury is ischemic preconditioning
(IPC), first introduced by Murry et al. [9]. The concept implies
a brief subcritical ischemic challenge which could mobilize
intrinsic protective mechanisms, increasing tolerance to a sub-
sequent deleterious ischemia. The induction of ischemic tolerance
has gained attention as a robust neuroprotective mechanism. In
fact, Roth et al. [10] have shown that IPC affords the retina
a greater degree of functional protection against ischemic damage
than any known neuroprotective agent, making retinal IPC
a particularly attractive area for further research. Although brief
ischemia or hypoxia serve as prototypical IPC stimuli, ischemic
tolerance can be induced by exposing animals or cells to diverse
type of endogenous or exogenous stimuli that are not necessarily
hypoxic or ischemic in nature, such as a moderate dose of bacterial
lipopolysaccharide (LPS) [11] or hyperthermia [12], among
others, supporting that one stressor can promote ‘‘cross-tolerance’’
to another [13]. However, one drawback of most preconditioning
stimuli is that they are also capable of producing injury with only
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minor changes in their intensity or duration. In the case of LPS-
induced retinal ischemic tolerance, for example, the intravitreal
injection of 0.1 mg LPS is too weak to elicit protection, 1 mg LPS is
highly effective as a preconditioning stimulus, but 5 mg LPS is
injurious per se [11]. Similarly, in the case of ischemia-induced
ischemic tolerance in the brain, 1 minute of ischemia is insufficient
to elicit tolerance, whereas 2 to 5 minutes of ischemia elicit
selective neuronal death [14,15]. This lack of a suitable safety
margin greatly limits the therapeutic utility of IPC in many clinical
settings. It has been shown that transient hypothermia is an
effective preconditioning stimulus for inducing tolerance to
ischemic injury in several systems, such as myocardium and brain
[16,17]. An attractive feature of hypothermic preconditioning
(HPC) is that it possesses a broad safety margin [18]. In that sense,
it was shown that a moderate level of hypothermia does not
represent a direct risk to neurons. Consequently, hypothermia can
serve as an effective preconditioning stimulus without presenting
a direct risk to neural tissue [18]. In fact, HPC is now considered
to be one of the most potent cardioprotective strategies available
and is used clinically to protect the heart against ischemia [19]. As
for the retina, it was reported that local hypothermia during
vitrectomy reduces retinal damage in pressure induced mild
ischemia [20]. Faberowski et al. [21] demonstrated a significant
neuroprotection of local hypothermia in a ligation-induced I/R
model in the rat retina, and the protective effect of lowering body
temperature during retinal ischemia has also been observed in
high intraocular pressure models in rabbit and mouse [22,23]. In
addition, lowering body temperature to 33uC during ischemia and
reperfusion in the retina markedly reduces ischemia-induced cell
loss in the ganglion cell layer (GCL) [24]. Although these results
indicate that intraischemic hypothermia limits retinal ischemic
damage, the efficacy of HPC against retinal I/R injury was not
previously examined. Thus, the aim of the present study was to
analyze the capacity of a short period of global or ocular
hypothermia applied before the ischemic event, for protecting the
retinal function and histology against I/R damage.
Materials and Methods
Ethics Statement
All animal procedures were in strict accordance with the
ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research. The ethic committee of the School of
Medicine, University of Buenos Aires (Institutional Committee
for the Care and Use of Laboratory Animals, (CICUAL))
approved this study.
Animals
Male Wistar rats (average weight 250640 g) were housed in
a standard animal room with food and water ad libitum under
controlled conditions of humidity, temperature (2162uC), and
luminosity (200 lux), under a 12-hour light/12-hour dark lighting
schedule (lights on at 7:00 AM). A total number of 104 animals
were used for the experiments, distributed as follows: for the study
of the effect of ocular cooling on body temperature: 4 animals; for
the studies of global hypothermia: 20 animals submitted to
ischemia in one eye and a sham procedure in the contralateral eye
which were maintained in normothermic conditions (10 animals)
or submitted to global hypothermia 24 h before ischemia (10
animals); for the studies of ocular hypothermia: 20 animals
submitted to ischemia in one eye and a sham procedure in the
contralateral eye which were maintained in normothermic
conditions or were submitted to ocular hypothermia 24 h before
ischemia; for the studies of the effect of ocular hypothermia on
glutamate uptake and glutamine synthetase: 40 animals with
ischemia in one eye and a sham procedure in the contralateral eye
with or without ocular hypothermia, and for the studies of the
effect of ocular hypothermia on glutamate injury: 20 animals
injected with vehicle in one eye and glutamate in the contralateral
eye, with or without ocular hypothermia applied 24 h before
injections.
Ischemia Methodology
Animals were anesthetized with ketamine hydrochloride
(150 mg/kg) and xylazine hydrochloride (2 mg/kg) administered
intraperitoneally. After topical instillation of proparacaine, the
anterior chamber was cannulated with a 30-gauge needle
connected to a pressurized bottle filled with sterile normal saline
solution. Retinal ischemia was induced by increasing intraocular
pressure (IOP) to 120 mmHg for exactly 40 min, as previously
described [2]. With this maneuver, complete ocular ischemia was
produced, characterized by loss of electroretinogram (ERG) b-
wave and cessation of flow in retinal vessels, determined by
funduscopic examination. The contralateral eye was cannulated
without raising IOP. During and after (before returning rats to the
animal house) ischemia, animals were kept normothermic with
heated blankets. A few animals (less than 5%) in which cataracts
developed due to lens injury, were not used any further in the
experiments.
Global and Ocular Hypothermia
Global hypothermia was achieved by applying ice packs to the
animal body while they were in a state of anesthesia induced by
ketamine and xylazine. The duration and depth of hypothermia
was fixed at 20 minutes and 33uC, as described by Yunoki et al.
[18]. The total duration of hypothermia was actually longer than
20 min, because approximately 10 min were required to cool the
animals from 37.5uC, and an additional 10-min period was
required to rewarm the animals by thermal covers. When the body
temperature was lowered to 33uC, the ocular temperature was
32uC. Control animals were anesthetized for the same period
without cooling. For core temperature measurements, a rectal
probe was inserted 6 cm into the rectum. In case the body
temperature of a rat deviated more than 0.5uC from the set point
for more than 5 min, this rat was excluded from the study.
For ocular cooling, a flow of standard water-soluble ultrasound
transmission gel (Gel Ultra Son, Dafton Acoplantes, Buenos Aires,
Argentina) cooled at 13uC was applied to one eye while limiting
systemic hypothermia. In a pilot experiment, the relationship
between ocular and systemic temperatures was determined by
simultaneously monitoring retroocular and rectal temperatures. In
these experiments, an incision was made 2 cm lateral to the eye
and a thermistor needle was implanted behind the ocular globe.
The results of this study showed that when the gel temperature was
lowered to 13uC, and the rectal temperature remained at 37.5uC,
the ocular globe temperature achieved was 32uC, while the
temperature of the contralateral eye remained normothermic
(Figure 1). These parameters for rectal and ocular temperatures
were used in subsequent experiments in which the placement of
the thermistor behind the ocular globe was omitted because of the
potential for direct injury by the probe. The duration of ocular
hypothermia was fixed at 20 minutes with a targeted retroocular
temperature of 32uC.
Electroretinography
Electroretinographic activity was assessed as follows: after 6 h of
dark adaptation, rats were anesthetized under dim red illumina-
tion. Phenylephrine hydrochloride and tropicamide were used to
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dilate the pupils, and the cornea was intermittently irrigated with
balanced salt solution to maintain the baseline recording and to
prevent keratopathy. Rats were placed facing the stimulus at
a distance of 20 cm. All recordings were completed within 20 min
and animals were kept warm during and after the procedure. A
reference electrode was placed through the ear, a grounding
electrode was attached to the tail, and a gold electrode was placed
in contact with the central cornea. A 15 W red light was used to
enable accurate electrode placement. This maneuver did not
significantly affect dark adaptation and was switched off during the
electrophysiological recordings. ERGs were recorded from both
eyes simultaneously and ten responses to flashes of unattenuated
white light (5 ms, 0.2 Hz) from a full-field/Ganzfeld stimulator
(light-emitting diodes) set at maximum brightness (9 cd s/m2
without filter) were amplified, filtered (1.5-Hz low-pass filter,
1000 high-pass filter, notch activated) and averaged (Akonic BIO-
PC, Buenos Aires, Argentina). The a-wave was measured as the
difference in amplitude between the recording at onset and the
trough of the negative deflection and the b-wave amplitude was
measured from the trough of the a-wave to the peak of the b-wave.
Electrophysiological responses were averaged for each run. Runs
were repeated 3 times with 5 min-intervals to confirm consistency
and the mean of these 3 runs was used for subsequent analysis.
The mean peak latencies and peak-to-peak amplitudes of the
responses from each group of rats were compared.
Oscillatory potentials (OPs) were assessed as previously de-
scribed [2]. Briefly, the same photic stimulator with a 0.2 Hz
frequency and filters of high (300 Hz) or low (100 Hz) frequency
were used. The amplitudes of the OPs were estimated by
measuring the heights from the baseline drawn between the
troughs of successive wavelets to their peaks. The sum of three OPs
was used for statistical analysis.
Histological Evaluation
Rats were sacrificed and their eyes were immediately
enucleated, immersed for 24 h in a fixative containing 4%
formaldehyde in 0.1 M phosphate buffer (pH 7.2) and embed-
ded in paraffin. Eyes were sectioned (5 mm) along the vertical
meridian through the optic nerve head. Microscopic images
were digitally captured with a Nikon Eclipse E400 microscope
(illumination: 6-V halogen lamp, 20 W, equipped with a stabi-
lized light source) via a Nikon Coolpix s10 camera. Sections
were stained with hematoxylin and eosin (H&E) and analyzed
by masked observers. The total retinal, photoreceptor outer
segment (PS), outer nuclear layer (ONL) outer plexiform layer
(OPL), inner plexiform layer (IPL), and inner nuclear layer
(INL) thickness (in mm) was measured for each eye. Measure-
ments (400x) were obtained at 1 mm dorsal and ventral from
the optic disc. For each eye, results obtained from four separate
sections were averaged and the mean of 5 eyes was recorded as
the representative value for each group.
Immunohistochemical Study
Antigen retrieval was performed by heating (90uC) slices for
30 min in citrate buffer and then preincubated with 2% normal
horse serum, 0.1% bovine serum albumin, and 0.4% Triton X-
100 in 0.01 M phosphate-buffered saline for 1 h. The sections
were then incubated overnight at 4uC with a mouse monoclonal
anti-Brn3a antibody (1:500 Millipore, Temecula, CA, USA). An
anti- anti-goat secondary antibody conjugated to Alexa Fluor 568
(1:500; Molecular Probes, Grand Island, NY, USA) was used.
After immunostaining, the sections were mounted with antifade
medium with the fluorescent nuclear stain DAPI (Vector
Laboratories, Burlingame, CA, USA). Some sections were treated
without the primary antibodies to confirm specificity. An Olympus
Figure 1. Temporal course of body, ipsilateral, and contralateral retroocular temperature during unilateral ocular cooling. A flow of
ultrasound transmission gel cooled at 13uC was applied to one eye, which achieved a temperature of 32uC. Note that when one eye was perfused
with the cooling gel, the contralateral eye, and the body temperature remained normothermic. Data are mean 6 SE (n: 4 animals).
doi:10.1371/journal.pone.0061656.g001
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BX50 microscope (Olympus, Tokyo, Japan) was used for
microscopic observations. Comparative digital images from
different samples were grabbed using identical time exposition,
brightness, and contrast settings.
L-3H-glutamate Uptake Assessment
The influx of L-3H-glutamate was assessed in a crude synap-
tosomal fraction of rat retinas, as previously described [2]. Retinas
were homogenized (1:9 w/v) in 0.32 M sucrose containing 1 mM
MgCl2, and centrifuged at 900 g for 10 min at 4uC. Nuclei-free
homogenates were further centrifuged at 30,000 g for 20 min. The
pellet was immediately resuspended in buffer HEPES-Tris,
containing 140 mM NaCl, 5 mM KCl, 2.5 mM CaCl2, 1 mM
MgCl2, 10 mM HEPES, 10 mM glucose, (adjusted to
pH 7.4 with Tris base) and aliquots (100 - 300 mg protein/
100 ml) were incubated with 100 ml of L-3H-glutamate (500,000–
800,000 dpm/tube, specific activity 17.25 Ci/mmol) and 10 mM
glutamate. After 5 min, glutamate uptake was terminated by
adding 4 ml of ice cold HEPES-Tris buffer. The mixture was
immediately poured onto Whatman GF/B filters under vacuum.
The filters were washed twice with 4 ml-aliquots of ice-cold buffer
and the radioactivity on the filters was counted in a liquid
scintillation counter. Non-specific uptake of L-3H-glutamate into
synaptosomes was assessed by adding an excess of glutamate
(10 mM).
Glutamine Synthetase Assessment
Each retina was homogenized in 200 ml of 10 mM potassium
phosphate, pH 7.2. Glutamine synthetase activity was assessed as
described [2]. Reaction mixtures contained 150 ml of retinal
homogenates and 150 ml of a stock solution (100 mM imidazole-
HCl buffer, 40 mM MgCl2, 50 mM b-mercaptoethanol, 20 mM
ATP, 100 mM glutamate and 200 mM hydroxylamine, adjusted
to pH 7.2). Tubes were incubated for 15 min at 37uC. The
reaction was stopped by adding 0.6 ml of ferric chloride reagent
(0.37 M FeCl3, 0.67 M HCl, and 0.20 M trichloroacetic acid).
Samples were placed for 5 min on ice. Precipitated proteins were
removed by centrifugation, and the absorbance of the super-
natants was read at 535 nm against a reagent blank. Under these
conditions, 1mmol of c-glutamylhydroxamic acids gives an
absorbance of 0.340. Glutamine synthetase specific activity was
expressed as mmoles of c-glutamylhydroxamate per hour per
milligram of protein.
Intravitreal Injection of Glutamate
Animals were anesthetized as previously described. A drop of
proparacaine (0.5%) was administered in each eye for local
anesthesia. With a Hamilton syringe (Hamilton, Reno, NV, USA)
and a 30-gauge needle, 4 ml of 0.3 M glutamate (estimated final
concentration 20 mM, considering a vitreous volume of 60 ml
[25]) in sterile pyrogen-free saline were injected into one eye of
anesthetized rats, while an equal volume of vehicle (saline solution)
was injected in the fellow eye. Injections were applied at 1 mm of
the limbus and the needle was left in the eye for 60 seconds; this
small volume prevented the increase in IOP and volume loss. The
dose of glutamate was selected on the basis of a previous report
[2]. Retinal function and histology were examined 7 days after
intravitreal injections of vehicle or glutamate.
Protein Level Assessment
Protein content was determined by the method of Lowry et al.
[26], using bovine serum albumin as the standard.
Statistical Analysis
Statistical analysis of results was made by a two-way analysis of
variance (ANOVA) followed by a Tukey’s test, as stated. For all
analyses, a value of P,0.05 was considered significant.
Results
Global Hypothermic Preconditioning
Figure 2 depicts the effect of global HPC on retinal functional
damage induced by increasing IOP to 120 mm Hg for 40 min.
One day before ischemia, a group of animals were kept at 33uC for
20 min, whereas control animals were maintained in normother-
mic conditions. The average amplitudes of ERG a- and b- waves
and OPs in non-ischemic eyes or 14 days after 40-min ischemia
without or with global HPC, as well as representative scotopic
ERG traces from rat eyes submitted to these treatments are shown
in Figure 2. A significant decrease in ERG a- and b- wave
amplitude was observed at 14 days after ischemia, while their
latencies remained unchanged (data not shown). Global HPC
significantly prevented the decrease in ERG a- and b-wave
amplitude induced by I/R. A similar profile was observed for OPs,
as shown in Figure 2. In non-ischemic eyes, global hypothermia
did not affect the ERG.
Figure 3 and Table 1 show the effect of a 20-min period of
global hypothermia on retinal histology. Figure 3A shows
a representative photomicrograph of non-ischemic retinas. Four-
teen days after 40-min ischemia, typical histopathological features
of ischemic damage were observed, showing marked reduction in
the total retinal, outer nuclear layer (ONL), inner nuclear layer
(INL), and inner plexiform layer (IPL) thickness (Figure 3C), and
a significant decrease in the number of Brn3a(+) cells in the
ganglion cell layer (GCL) (Figure 3G), as compared with control
retinas (Figure 3A and 3E). Global HPC (Figure 3D) which did not
show effect per se (Figure 3B and 3F), significantly prevented the
decrease in total retinal, INL, IPL thickness, and in the number of
Brn3a(+) cells in the GCL (Figure 3H).
Ocular Hypothermic Preconditioning
The protective effect of ocular HPC against I/R injury was
analyzed at functional and histological level. The average
amplitudes of scotopic ERG a- and b- waves and OPs in control
animals or animals submitted to ischemia, without or with ocular
hypothermia applied 24 h before ischemia, as well as representa-
tive scotopic ERG traces from rats submitted to these treatments
are shown in Figure 4. Ocular hypothermia significantly prevented
the decrease in the ERG a-wave, b-wave, and OP amplitude
induced by I/R. The protective effect of ocular hypothermia was
also evident at histological level (Figure 5 and Table 2). Ocular
hypothermia significantly prevented the decrease in total retinal,
INL, and IPL thickness, and the number of Brn3a(+) cells in the
GCL induced by 40- min ischemia. Ocular hypothermia did not
affect the decrease in ONL thickness induced by I/R (Table 2).
Involvement of Glutamate in Ocular Hypothermic
Preconditioning
Figure 6 shows L-3H-glutamate uptake and glutamine synthe-
tase activity in retinas from control eyes and eyes submitted to
ischemia without or with ocular hypothermia applied 24 h before
ischemia, and assessed 3 days after ischemia. These parameters
significantly decreased in ischemic retinas as compared with non-
ischemic retinas. Ocular hypothermia, which did not affect these
parameters in non-ischemic eyes, significantly prevented the effect
of ischemia.
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Figure 2. Effect of global HPC on retinal function. Scotopic ERGs from rats subjected to 40-min ischemia without or with global hypothermia
applied 24 h before ischemia, and registered 14 days after ischemia. Upper panel: average amplitudes of scotopic ERG a-wave, b-wave, and OPs. A
significant decrease in the ERG a-wave, b-wave, and OP amplitude was observed in eyes exposed to 40-min ischemia without global HPC. In animals
submitted to global HPC, a significant preservation of the ERG a-wave, b-wave, and OP amplitude was observed. Data are mean 6 SE (n: 10 eyes/
group). **P,0.01, by Tukey’s test. Lower panel: Representative scotopic ERG and OP traces from a non-ischemic eye without or with local HPC, and
from an eye subjected to 40-min ischemia without or with global HPC applied 24 h before ischemia.
doi:10.1371/journal.pone.0061656.g002
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The effect of an intravitreal injection of glutamate without or
with ocular HPC on scotopic ERG and OPs is shown in Figure 7.
Glutamate induced a significant decrease in the ERG b-wave and
OP amplitude (but not their latencies or the a-wave amplitude) as
compared with vehicle-injected eyes, whereas ocular hypothermia
applied 24 h before glutamate injection significantly abrogated the
effect of glutamate. The effect of an intravitreal injection of
glutamate without or with ocular hypothermia applied 24 h before
glutamate injection on retinal histology is depicted in Figure 8 and
Table 3. Glutamate induced a significant decrease in the total
retinal, INL, and IPL thickness, and in Brn3a(+) cell number
(Figure 8B and 8E) as compared with vehicle injected eyes
(Figure 8A and 8D), whereas ocular hypothermia prevented the
effect of glutamate on these parameters (Figure 8C and 8F).
Similar results in retinal function and histology were observed in
non-injected eyes and eyes intravitreally injected with vehicle (data
not shown).
Figure 3. Effect of global HPC on retinal histology. Upper panel: Representative photomicrographs showing histological appearance of non-
ischemic retinas without (A) or with global HPC (B), ischemic retinas 14 days after 40 min of ischemia without global HPC (C), and ischemic retinas
from animals submitted to global HPC, 24 h before ischemia (D). Severe retinal damage is shown in the retina from eyes submitted to ischemia
without global HPC, whereas in animals submitted to global HPC, the retinal structure was notably preserved. Lower panel: Immunohistochemical
detection of Brn3a(+) cells in the GCL from all the experimental groups. A decrease in GCL Brn3(+) cell number was observed in ischemic retinas
without global HPC (G) as compared with non-ischemic eyes (E), whereas global HPC, which showed no effect in control eyes (F), partly preserved
Brn3a(+) cell count in ischemic eyes (H). GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; ONL, outer nuclear layer, OS, outer
segment of photoreceptors.
doi:10.1371/journal.pone.0061656.g003
Table 1. Histological analysis of the effect of global HPC on retinal ischemic damage.
Total PS ONL OPL INL IPL Brn3a (+) cell number
Control 132.065.8 27.061.4 40.061.4 6.160.3 21.861.4 34.362.8 5.560.2
Hypothermia 134.264.3 27.161.2 39.961.5 6.260.4 20.260.8 35.060.8 5.660.2
Ischemia 99.762.0** 24.762.2 31.361.0* 6.060.9 15.360.5** 18.96 1.1** 3.46 0.3**
Global HPC+ischemia 116.064.3*,a 27.261.6 36.263.0 5.961.5 17.560.7*,b 30.66 1.0 a 4.960.4*,a
Total retinal and retinal layer thicknesses (in mm) in non-ischemic or ischemic eyes without or with global HPC. Retinal ischemia induced a significant decrease in total
retinal, ONL, INL and IPL thickness, and in GCL Brn3a(+) cell number. The alterations in total retinal, INL, and IPL (but not ONL) thickness, and in retinal ganglion cell
number were partially prevented by global HPC, which showed no effects in non-ischemic eyes on these parameters. Data are mean 6 SEM (n = 5 eyes per group).
*P,0.05 and,
**P,0.01 vs non-ischemic eyes;
ap,0.05 and,
bp,0.01 vs. ischemic eyes without global HPC, by Tukey’s test.
PS, photoreceptor outer and inner segment; OPL, outer plexiform layer; ONL, outer nuclear layer; IPL, inner plexiform layer; INL, inner nuclear layer.
doi:10.1371/journal.pone.0061656.t001
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Figure 4. Functional protection against I/R damage induced by ocular HPC. Upper panel: Average amplitudes of scotopic ERG a-wave, b-
wave and OPs. In eyes submitted to 40-min ischemia, local HPC significantly prevented the decrease in the amplitude of ERG b- (but not a-) wave and
OP amplitude assessed 14 days after 40-min ischemia. Data are mean6 SE (n: 10 eyes/group). **P,0.01, by Tukey’s test. Lower panel: Representative
scotopic ERG and OP traces from all the experimental groups.
doi:10.1371/journal.pone.0061656.g004
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Discussion
For the first time, the present results indicate that transient
global or ocular hypothermia applied 24 h before an ischemic
event, significantly prevented the effect of I/R on retinal
function and histology. Brn3a is a POU domain transcription
factor that is specifically expressed in the nuclei of RGCs [27].
In the retinas from ischemic eyes, a significant loss of RGCs
was observed, as shown by Brn3a immunohistochemistry,
whereas global or ocular HPC significantly prevented the loss
of RGCs induced by I/R.
Hypothermia is one of the oldest, yet most effective, intrais-
chemic treatments for limiting cellular injury. Systemic or focal
cooling has been shown to provide a beneficial effect in the context
of cerebrovascular, cardiovascular, and other types of surgeries
[28–30]. In experimental studies, hypothermia has been referred
to as ‘‘the gold standard’’ against which other ischemic therapies
should be compared [31,32] and has been described as ‘‘the most
potent therapeutic approach for reducing experimental ischemic
brain injury identified to date’’ [31]. These descriptions refer to
the well established protective effects of hypothermia when
delivered during ischemia in several systems, including the retina
Figure 5. Histological protection against I/R damage induced by local HPC. Upper panel: Severe retinal damage is shown in the retina from
eyes submitted to ischemia without local HPC (C) as compared with non-ischemic eyes (A), whereas local HPC applied 24 h before ischemia (D),
notably preserved the retinal structure. Lower panel: A similar profile was observed for Brn3a(+) cell number in the GCL. Local HPC did not affect
retinal histology and Brn3a(+) cell number in non-ischemic eyes (B and F, respectively). GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner
nuclear layer; ONL, outer nuclear layer, OS, outer segment of photoreceptors.
doi:10.1371/journal.pone.0061656.g005
Table 2. Histological analysis of the effect of ocular HPC on retinal ischemic damage.
Total PS ONL OPL INL IPL
Brn3a (+) cell
number
Control 133.963.5 27.561.1 41.661.5 6.460.4 20.560.4 35.362.5 5.260.3
Hypothermia 135.763.9 26.760.9 40.961.0 6.660.3 19.561.0 34.861.0 5.660.2
Ischemia 101.761.8** 23.261.5 30.360.7** 5.960.4 16.560.6** 20.56 1.0** 3.56 0.2**
Ocular HPC+ischemia 118.264.6*,a 28.861.6 34.661.2** 6.860.3 20.360.4*,b 29.56 1.5a 5.360.2 a
Effect of ocular HPC on total retinal and retinal layer thicknesses (in mm) in non-ischemic or ischemic eyes. Ischemia decreased total retinal, ONL, INL and IPL thickness,
and GCL Brn3a(+) cell number. Ocular HPC which showed no effects in non-ischemic eyes, prevented the alterations in total retinal, INL, and IPL (but not ONL) thickness,
and in retinal ganglion cell number. Data are mean 6 SEM (n = 5 eyes per group).
*P,0.05 and,
**P,0.01 vs non-ischemic eyes;
ap,0.05 and
bp,0.01 vs. ischemic eyes without ocular HPC, by Tukey’s test.
PS, photoreceptor outer and inner segment; OPL, outer plexiform layer; ONL, outer nuclear layer; IPL, inner plexiform layer; INL, inner nuclear layer.
doi:10.1371/journal.pone.0061656.t002
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[20,24]. The present results indicate that transient global or ocular
hypothermia can also protect the retina when applied 24 h before
an ischemic event, which indicate that the simultaneity of
hypothermia with ischemia is not a necessary requirement for its
protective effect. Preconditioning differs from neuroprotection in
several aspects. The prophylactic approaches to neuroprotection
in essence represent acute or chronic pretreatments in which the
drug or manipulation are present when damage occurs, whereas in
preconditioning, the singular or final treatment precedes the
deleterious event by many hours or days, and the obligatory
genomic reprogramming that largely defines the tolerant pheno-
type is promoted [13]. Thus, it seems likely that hypothermia
could behave as a neuroprotectant or a preconditioning stimulus,
depending on the time of its application with respect to the
ischemic episode.
Several stimuli are able to induce retinal ischemic tolerance,
such as LPS [11], inhaled carbon monoxide [33], and hyperbaric
oxygen [34], among others. Unfortunately, most stimuli that
induce tolerance are also capable of inflicting injury if their
intensity or duration is slightly increased. It is therefore of
considerable importance to identify effective preconditioning
stimuli that have better safety margins and entail less risk.
Although deep systemic hypothermia may have several side effects,
including increased peripheral vascular resistance, increased
cardiac afterload, bradycardia, acidosis, increased blood viscosity,
cerebrovascular constriction, and abnormalities in blood co-
agulation [35,36], these side effects are limited and/or manageable
at mild-to-moderate levels of hypothermia [18], as those used in
this report. In fact, the safety of even longer periods and of higher
magnitude of hypothermia than those used herein has been shown
in the brain from rodents and humans [17,18,37–39]. In this vein,
it was shown that as many as 3 h of lowering the temperature at
30uC does not provoke damage to the brain [40]. In the
experimental conditions used in this report, no significant effects
of global or ocular hypothermia were observed in non-ischemic
eyes at functional and histological level, supporting the safety of
these procedures. Moreover, several clinical reports demonstrate
that prolonged periods (that is, days-weeks) of hypothermia in
a similar temperature range (32–33uC) are well tolerated by
patients [41–43], which suggest that HPC could potentially serve
as a tolerance-inducing stimulus in a clinical setting.
Yunoki et al. [18] showed a similar magnitude of protection
against brain ischemia by focal or global cooling. However, at the
experimental conditions used in this report, global HPC appeared
to be more effective than ocular HPC in the protection of retinal
function against ischemic damage. There is no ready explanation
for this discrepancy. It has been demonstrated that repeated cycles
of temporary ischemia in a remote organ (i.e. remote precondi-
tioning) can activate protective pathways in the target organ,
including the heart [44] and brain [45]. Therefore, although there
are no data on the neuroprotective effect of remote precondition-
ing in the retina, it is tempting to speculate that besides ocular
cooling, global HPC could protect the retina by a remote
preconditioning mechanism. Notwithstanding, it seems likely that
by changing the experimental conditions (time and temperature),
it would be possible to achieve a higher magnitude of protection by
ocular HPC which, contrary to hypothermia applied through
whole body, is not associated with hemodynamic imbalance, and
can be used to minimize side effects of systemic hypothermia,
eventually, without significantly compromising the magnitude of
the tolerance effect.
It has been demonstrated that retinas subjected to mild or
moderate hypothermia had a decrement in neuronal energy
metabolism which is fully restored once the retinas were placed
under normothermic conditions [46]. However, since global or
ocular HPC were applied 24 h before the ischemic episode, it
Figure 6. Effect of ischemia and ocular HPC on retinal glutamate uptake and glutamine synthetase activity. Three days after ischemia,
a significant decrease of glutamate uptake (panel A) and glutamine synthetase activity (panel B) was observed in ischemic retinas, whereas local HPC,
which showed no effect per se in non-ischemic eyes, significantly prevented the effect of ischemia on these parameters. Data are mean 6 SEM
(n = 10–12 animals per group). **P,0.01, by Tukey’s test.
doi:10.1371/journal.pone.0061656.g006
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Figure 7. Effect of an intravitreal injection of glutamate without or with local HPC on retinal function. Eyes were intravitreally injected
with vehicle or glutamate without or with local HPC applied 24 h before injections. Glutamate induced a significant decrease in the ERG b-wave and
OP amplitude, whereas local HPC significantly prevented the effect of glutamate on these parameters. Upper panel: Average amplitudes of scotopic
ERG a- and b-wave, and OP amplitudes. Shown are means 6 SEM (n = 10 animals/group). *P,0.05, and **P,0.01, by Tukey’s test. Lower panel:
Representative scotopic ERG and OP traces from eyes injected with glutamate without or with local HPC.
doi:10.1371/journal.pone.0061656.g007
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seems unlikely that the reduction in retinal energy usage could
account for the protective effect of HPC.
Preconditioning stimuli capable of eliciting tolerance are, for the
most part, rather nonspecific in their actions on target tissues. It
would clearly be of benefit to identify the mechanistic under-
pinnings of ischemic tolerance to develop more specific and
clinically applicable therapies. The link between excitotoxicity and
retinal ischemic damage had received considerable experimental
Figure 8. Effect of glutamate without or with local HPC on retinal histology. Representative photomicrographs showing histological
appearance of retinas obtained 7 days after injection of vehicle (A, D) or glutamate without (B, E) or with local HPC applied 24 h before glutamate
injection (C, F). Glutamate induced alteration in the retinal structure (upper panel) and GCL Brn3a(+) cell number (lower panel), whereas local HPC
prevented histological alterations from glutamate damage. GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; ONL, outer
nuclear layer, OS, outer segment of photoreceptors.
doi:10.1371/journal.pone.0061656.g008
Table 3. Protective effect of ocular HPC on retinal damage induced by glutamate.
Total Thickness PS ONL OPL INL IPL Brn3a (+) cell number
Vehicle 133.963.5 27.561.1 41.660.5 6.460.3 20.560.4 35.360.5 5.260.2
Glutamate 119.462.0** 28.860.3 43.560.6 8.161.0 18.560.3** 19.460.8** 3.460.3**
Ocular
HPC+Glutamate
131.762.8 30.461.7 43.360.6 8.860.2 21.960.3b 22.76 0.7**,a 4.66 0.3*,a
Total retinal and retinal layer thicknesses (in mm) and retinal ganglion cell number in vehicle- or glutamate-injected eyes without or with ocular HPC. Glutamate induced
a decrease in total retinal, INL, and IPL thickness and Brn3a(+) cell number, which was significantly prevented by ocular HPC. Data are mean 6 SEM (n = 5 eyes per
group).
*P,0.05,
**P ,0.01 vs. vehicle-injected eyes,
aP ,0.05, and,
bP,0.01 vs. glutamate-injected eyes without ocular HPC, by Tukey’s test.
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support. Glial cells, mainly astrocytes and Mu¨ller cells, surround
glutamatergic synapses, and express glutamate transporters and
the glutamate-metabolizing enzyme, glutamine synthetase [46–
48]. Glutamate is transported into glial cells and amidated by
glutamine synthetase to the non-toxic aminoacid glutamine.
Glutamine is then released by glial cells and taken up by neurons,
where it is hydrolyzed by glutaminase to form glutamate again,
completing the retinal glutamate/glutamine cycle [49,50]. In this
way, the neurotransmitter pool is replenished and glutamate
neurotoxicity is prevented. In order to get insight into the
mechanism involved in the protective effect of retinal HPC,
glutamate uptake and glutamine synthetase activity were assessed
in ischemic retinas without or with ocular HPC. As previously
shown, retinal ischemia induced a significant decrease in both
parameters [2] which was prevented by ocular HPC. In this way,
the decrease in glutamate uptake and glutamine synthetase activity
in ischemic retinas could contribute to an excessive increase in
glutamate synaptic level, whereas the enhancement of glutamate
influx and glutamine synthetase activity by ocular HPC may
protect the retina from I/R injury. Moreover, as shown herein, the
intravitreal injection of supraphysiological concentrations of
glutamate provoked significant alterations in retinal function and
histology which were prevented by ocular HPC. Thus, without
excluding the activation of other transduction pathways involved
in retinal ischemic tolerance, such as nitric oxide [11], adenosine
[51], KATP channels [52], PKC [52], and vascular endothelial
growth factor [53], among others, these results support that
reducing glutamate synaptic levels could represent a crucial step in
the retinal protection induced by HPC against ischemic damage.
At retinal level, glutamate uptake and glutamine synthetase are
mainly localized in Mu¨ller’s cells [54]. Therefore, the fact that
HPC prevented the effect of I/R on glutamate uptake and
glutamine synthetase activity, points at Mu¨ller cells as putative
target for the protective effect of HPC on I/R damage, albeit the
involvement of other cellular type(s) cannot be ruled out.
Moreover, since ocular HPC was able to protect retinal function
and histology against glutamate-induced neurotoxicity, HPC could
have promise for application in retinal diseases which involve
excitotoxicity-mediated retinal cell death.
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